A FUTURE BEYOND ALZHEIMER'S
Live / Applied — Fourth extension granted (statement of use) (as of 12 Dec 2025)
What this means for you
Not registered yet, but its 30 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97697311
- Mark type
- Stylized text
- Filed
- 30 Nov 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, viral vectors with human genes for treating age-related diseases such as Alzheimer's disease
- Class 042 — Scientific and technological services: Gene therapy research
- Class 044 — Medical, beauty and agricultural services: Medical services in the field of clinical gene therapy
Owner
- Telocyte, LLC, Ada, MI, US
- Telocyte, LLC, Ada, MI, US
Prosecution history
- 13 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 4 GRANTED
- 12 Dec 2025 — SOU EXTENSION 4 FILED
- 12 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2025 — SOU EXTENSION 3 GRANTED
- 13 May 2025 — SOU EXTENSION 3 FILED
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2024 — SOU EXTENSION 2 GRANTED
- 18 Sept 2024 — SOU EXTENSION 2 FILED
- 18 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 23 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2024 — SOU EXTENSION 1 GRANTED
- 22 May 2024 — SOU EXTENSION 1 FILED